EBOS GROUP LTD

ASX: EBO (EBOS FPO NZ [EBO])

Last update: 29 minutes ago

36.65

-0.15 (-0.41%)

Previous Close 36.80
Open 36.79
Volume 3,556
Avg. Volume (3M) 99,579
Market Cap 7,393,257,984
Price / Earnings (TTM) 28.63
Price / Earnings (Forward) 27.78
Price / Sales 0.550
Price / Book 2.93
52 Weeks Range
31.04 (-15%) — 38.09 (3%)
Earnings Date 27 Aug 2025
TTM Dividend Yield 2.98%
Profit Margin 1.95%
Operating Margin (TTM) 3.58%
Diluted EPS (TTM) 1.29
Quarterly Revenue Growth (YOY) -9.00%
Quarterly Earnings Growth (YOY) -18.90%
Total Debt/Equity (MRQ) 70.12%
Current Ratio (MRQ) 1.22
Operating Cash Flow (TTM) 432.61 M
Levered Free Cash Flow (TTM) 338.65 M
Return on Assets (TTM) 4.15%
Return on Equity (TTM) 10.37%

Market Trend

Short Term Medium Term
Industry Medical Distribution (AU) Mixed Mixed
Medical Distribution (Global) Bearish Bearish
Stock EBOS FPO NZ [EBO] - -

AIStockmoo Score

0.9
Analyst Consensus 0.0
Insider Activity NA
Price Volatility -0.5
Technical Moving Averages 0.0
Technical Oscillators 4.0
Average 0.88

Similar Stocks

Stock Market Cap DY P/E (TTM) P/B
EBO 7 B 2.98% 28.63 2.93
SIG 36 B 0.17% - 39.27
PGC 654 M - 39.50 2.10
CYC 161 M - - 2.72

Ebos is the largest pharmaceutical wholesaler and distributor across Australia and New Zealand. It services community pharmacies and hospitals, which contribute around 60% and 30% of revenue, respectively. Drug pricing and wholesale margins for PBS medicine are governed by the Australian government’s Pharmaceutical Benefits Scheme, or PBS. Wholesale gross margins are capped at 7% for community pharmacy and 10% for hospitals, and ongoing price reform typically results in low-single-digit revenue growth. Aside from pharma distribution, Ebos operates an animal health product wholesale, manufacturing and retail business, as well as undertaking third party logistics services. These segments are smaller contributors to group revenue but due to the unregulated nature are higher-margin operations.

Sector Healthcare
Industry Medical Distribution
Investment Style Mid Core
% Held by Insiders 8.83%
% Held by Institutions 25.12%

No data within this time range.

No data within this time range.

The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.

Portfolio

AI Template

Your price alert

Risk Profile

| | | | |
Conservative
Moderate Conservative
Moderate
Moderate Aggressive
Aggressive
Margin of Safety (EP)
Partial Profit (TP1)
Target Profit (TP2)
Maximum Loss (SL)

Disclaimer: The above is for illustrative purposes only and is NOT investment advice. Seek advice from a qualified financial professional.

Entry Price (EP)

Take Profit 1 (TP1)

Take Profit 2 (TP2)

Stop Loss (SL)

52W Range
 
52WL
 
52WH
SL
EP
TP1
TP2

All alert prices are within 52 weeks price range

Realized Profit -
Unrealized Profit -
Dividend Received 2025 -
Total Profit -
Avg. Return -
Quantity (Buy) -
Avg. Price (Buy) -
Quantity (Sold) -
Avg. Price (Sold) -
No stocks matching your criteria